Grippol® Plus is ours!
The Ministry of Healthcare of the Russian Federation provided NPO Petrovax Pharm an official approval for manufacture of local influenza vaccine GrippolÒ Plus based on influenza virus antigens manufactured by Saint Petersburg Research Institute of Vaccines and Sera of the FMBA, Russia.
It is a joint project of two companies, implemented within an agreement on long-term strategic cooperation in the field of development, manufacture and implementation in practical healthcare of modern local vaccines, signed last year.
Before 2016 GrippolÒ plus was manufactured using imported antigens. In 2015 modernized capacities of the Research Institute of Vaccines and Sera completed implementation of technology of manufacture of highly purified antigens according to GMP standards free of mercury-containing preservatives.
Now all components of GrippolÒ Plus will be fully manufactured in Russia.